Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Adaptor-related protein complex 5 subunit zeta-1 (AP5Z1) is a large subunit of the AP-5 adaptor protein complex, which mediates intracellular protein traffic, particularly a sorting step from late endosomes to the Golgi apparatus. AP5Z1 is implicated in endosomal transport, lysosomal homeostasis, and efficient homologous recombination-mediated DNA repair. Damaging variants in AP5Z1 are causative for SPG48, a complicated form of hereditary spastic paraplegia characterized by progressive neurodegeneration and aberrant endolysosomes. AP5Z1 is not generally considered a classical therapeutic target such as a receptor or enzyme, and no drugs are currently known to specifically target this protein[1][2][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Adaptor-related protein complex 5 subunit zeta-1 (AP5Z1).